Genmab A/S (GMAB) Short Interest
Nasdaq • GMAB • US3723032062
As of Oct 21, 2026, ORTEX estimated 1.1% of free float sold short, 1.5 days to cover, cost to borrow 0.86%. Sign up for live short interest data.
Nasdaq • GMAB • US3723032062
As of Oct 21, 2026, ORTEX estimated 1.1% of free float sold short, 1.5 days to cover, cost to borrow 0.86%. Sign up for live short interest data.
This page tracks how heavily Genmab A/S (Nasdaq:GMAB) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Genmab A/S (Nasdaq: GMAB) has a market capitalization of $32.02B. Last close $55.12 (as of 2026-11-05); 52-week range $23.62 to $59.97. ORTEX data as of 2026-10-21: short interest was 1.14% of free float, 1.5 days to cover and the average cost to borrow was 0.86%. Sign up for live short interest data.